Filtros de búsqueda

Lista de obras de Anna Maria Rachiglio

AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib.

artículo científico publicado en 2006

Activity of gefitinib in a non-small-cell lung cancer patient with both activating and resistance EGFR mutations

artículo científico publicado en 2013

Assessment of high-sensitive methods for the detection of EGFR mutations in circulating free tumor DNA from NSCLC patients

artículo científico publicado en 2015

BRAF V600E mutation in metastatic colorectal cancer: Methods of detection and correlation with clinical and pathologic features.

artículo científico publicado en 2016

Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol

scientific article published on 09 September 2019

Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial.

artículo científico publicado en 2016

Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trial.

artículo científico publicado en 2014

Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment.

artículo científico publicado en 2017

Comment on 'a comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens'

artículo científico publicado en 2012

Detection of EGFR mutations by TaqMan mutation detection assays powered by competitive allele-specific TaqMan PCR technology

artículo científico publicado en 2013

Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.

artículo científico publicado en 2011

Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach.

artículo científico publicado en 2010

Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells.

artículo científico publicado en 2009

Genomic Profiling of KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer Patients Reveals Novel Mutations in Genes Potentially Associated with Resistance to Anti-EGFR Agents

scientific article published on 20 June 2019

Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.

artículo científico publicado en 2015

Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives

artículo científico publicado en 2020

Leptin signaling in breast cancer: An overview

artículo científico publicado en 2008

Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities

artículo científico publicado en 2013

Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panel

artículo científico publicado en 2013

The Presence of Concomitant Mutations Affects the Activity of EGFR Tyrosine Kinase Inhibitors in EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Patients

artículo científico publicado en 2019

The S492R EGFR ectodomain mutation is never detected in KRAS wild-type colorectal carcinoma before exposure to EGFR monoclonal antibodies

scientific article published on 23 September 2013

The role of circulating free DNA in the management of NSCLC

scientific article published on 29 November 2018

The role of the EGFR signaling in tumor microenvironment.

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda